<DOC>
	<DOCNO>NCT00573794</DOCNO>
	<brief_summary>To assess long-term safety maintenance response adalimumab subject ulcerative colitis .</brief_summary>
	<brief_title>Long-term Open-label Safety Efficacy Study Adalimumab Subjects With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject must successfully enrol complete either M06826 study M06827 study Subject judge generally good health determine principal investigator Subject respond weekly adalimumab therapy M06826 M06827 Subject consider investigator , reason , unsuitable candidate Female subject pregnant breastfeeding consider become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>